Clinical Trial Update: Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety, tolerability, and efficacy of orally administered PTL201 in multiple sclerosis patients with spasticity-rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• PTL201

Snippet

Sponsor: PhytoTech Therapeutics, Ltd. | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN